Solve medication-interaction errors by treating interactions as language problems

Solve medication-interaction errors by treating interactions as language problems targets a $15.0B = 100,000 healthcare orgs (hospitals, chains, PBMs, large pharmacy groups, EHR partners) x $150K ACV average total addressable market with medium saturation and a year-over-year growth rate of 12-18% -- clinical decision support and medication safety markets expanding with digitization and regulatory focus.

Key trends driving demand: LLM accuracy improvements -- enables reliable interpretation of nuanced clinical text and free-text prescriptions; FHIR/interoperability push -- makes real-time EHR integration feasible for middleware CDS; Rising polypharmacy & aging populations -- increases absolute need for better interaction detection; Value-based care & quality metrics -- payers and hospitals motivated to reduce adverse drug events.